Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

NCT04691622 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Viral Infection
Hematopoietic Stem Cell Transplantation (HSCT)
Primary Immunodeficiency Disorders (PID)

Interventions

BIOLOGICAL: Norovirus -specific T-cell (NST) therapy

Sponsor

Children's National Research Institute